Akeso shares surge as cancer drug achieves key milestone in China trial
Source: SeekingAlpha
2025-08-27 00:30:38 ET
More on Akeso
- Summit claims late-stage trial win for lung cancer therapy
- Historical earnings data for Akeso
- Financial information for Akeso
Read the full article on Seeking Alpha
For further details see:
Akeso shares surge as cancer drug achieves key milestone in China trial
Akeso
NASDAQ: AKESF
AKESF Trading
-6.92% G/L:
$12.10 Last:
2,287 Volume:
$12.174 Open:
